TATA AIA LIFE INSURANCE CO LTD UNIT LINK ED MULTI CAP FUND
Institution · data to Jun 2026
Disclosed value
₹1,624 Cr
Jun 2026 closes
At current prices
…
Current holdings
5
Tracked since
Mar 2020
Portfolio value over time
Sum of disclosed holdings across all combined entities, valued at each quarter's closing price.
Current holdings (Jun 2026)
| Company | Holding | QoQ | Value |
|---|---|---|---|
| Syrma SGS Technology Ltd | 2.67% | 0.01 | ₹708 Cr |
| Concord Biotech Ltd | 2.48% | 0.57 | ₹330 Cr |
| Atul Ltd | 1.17% | flat | ₹226 Cr |
| Alembic Pharmaceuticals Ltd | 1.15% | 0.66 | ₹186 Cr |
| Prudent Corporate Advisory Services Ltd | 1.40% | 0.13 | ₹174 Cr |
Portfolio Summary
Jun 2026As of Jun 2026, TATA AIA LIFE INSURANCE CO LTD UNIT LINK ED MULTI CAP FUND — an institution tracked through public shareholding filings — disclosed 5 holdings in Indian listed companies worth ₹1,624 crore. The same holdings-at-filing-value basis put it at ₹1,209 crore in Mar 2026 (+34.3%). Solomo carries these filings back to Mar 2020.
Largest disclosed positions in Jun 2026: Syrma SGS Technology Ltd (SYRMA — 2.67% of the company, ₹708 crore); Concord Biotech Ltd (CONCORDBIO — 2.48% of the company, ₹330 crore); Atul Ltd (ATUL — 1.17% of the company, ₹226 crore); Alembic Pharmaceuticals Ltd (APLLTD — 1.15% of the company, ₹186 crore); Prudent Corporate Advisory Services Ltd (PRUDENT — 1.40% of the company, ₹174 crore).
Changes in the Jun 2026 filings: Stake raised in Concord Biotech Ltd (+0.57 pp). Stake reduced in Alembic Pharmaceuticals Ltd (−0.66 pp), Prudent Corporate Advisory Services Ltd (−0.13 pp), Syrma SGS Technology Ltd (−0.01 pp).
| Quarter | Disclosed value | Change |
|---|---|---|
| Jun 2026 | ₹1,624 Cr | +34.3% |
| Mar 2026 | ₹1,209 Cr | −9.2% |
| Dec 2025 | ₹1,331 Cr | −0.6% |
| Sep 2025 | ₹1,339 Cr | −13.4% |
| Jun 2025 | ₹1,547 Cr | +82% |
| Mar 2025 | ₹850 Cr | −10.6% |
| Dec 2024 | ₹950 Cr | +5.2% |
| Sep 2024 | ₹904 Cr | +54.8% |